Schonfeld Strategic Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.29M | Buy |
520,284
+501,818
| +2,718% | +$7.04M | 0.05% | 392 |
|
|
2025
Q1 | $289K | Sell |
18,466
-4,534
| -20% | -$70.9K | ﹤0.01% | 1681 |
|
|
2024
Q4 | $320K | Sell |
23,000
-7,349
| -24% | -$102K | ﹤0.01% | 1526 |
|
|
2024
Q3 | $282K | Buy |
30,349
+14,175
| +88% | +$132K | ﹤0.01% | 1536 |
|
|
2024
Q2 | $150K | Buy |
+16,174
| New | +$150K | ﹤0.01% | 1712 |
|
|
2023
Q1 | – | Sell |
-28,100
| Closed | -$416K | – | 1999 |
|
|
2022
Q4 | $416K | Buy |
+28,100
| New | +$416K | ﹤0.01% | 1607 |
|
|
2022
Q2 | – | Sell |
-17,996
| Closed | -$347K | – | 2430 |
|
|
2022
Q1 | $347K | Buy |
+17,996
| New | +$347K | ﹤0.01% | 1534 |
|